1. Home
  2. EOLS vs CYH Comparison

EOLS vs CYH Comparison

Compare EOLS & CYH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EOLS
  • CYH
  • Stock Information
  • Founded
  • EOLS 2012
  • CYH 1985
  • Country
  • EOLS United States
  • CYH United States
  • Employees
  • EOLS N/A
  • CYH N/A
  • Industry
  • EOLS Biotechnology: Pharmaceutical Preparations
  • CYH Hospital/Nursing Management
  • Sector
  • EOLS Health Care
  • CYH Health Care
  • Exchange
  • EOLS Nasdaq
  • CYH Nasdaq
  • Market Cap
  • EOLS 493.5M
  • CYH 397.9M
  • IPO Year
  • EOLS 2018
  • CYH 1991
  • Fundamental
  • Price
  • EOLS $7.19
  • CYH $2.94
  • Analyst Decision
  • EOLS Strong Buy
  • CYH Hold
  • Analyst Count
  • EOLS 5
  • CYH 8
  • Target Price
  • EOLS $21.25
  • CYH $3.57
  • AVG Volume (30 Days)
  • EOLS 899.1K
  • CYH 1.5M
  • Earning Date
  • EOLS 11-05-2025
  • CYH 10-22-2025
  • Dividend Yield
  • EOLS N/A
  • CYH N/A
  • EPS Growth
  • EOLS N/A
  • CYH N/A
  • EPS
  • EOLS N/A
  • CYH N/A
  • Revenue
  • EOLS $277,941,000.00
  • CYH $12,647,000,000.00
  • Revenue This Year
  • EOLS $14.01
  • CYH N/A
  • Revenue Next Year
  • EOLS $29.46
  • CYH $2.46
  • P/E Ratio
  • EOLS N/A
  • CYH N/A
  • Revenue Growth
  • EOLS 17.15
  • CYH 0.81
  • 52 Week Low
  • EOLS $5.71
  • CYH $2.24
  • 52 Week High
  • EOLS $17.82
  • CYH $6.29
  • Technical
  • Relative Strength Index (RSI)
  • EOLS 42.33
  • CYH 55.10
  • Support Level
  • EOLS $7.19
  • CYH $2.86
  • Resistance Level
  • EOLS $7.75
  • CYH $3.04
  • Average True Range (ATR)
  • EOLS 0.31
  • CYH 0.11
  • MACD
  • EOLS 0.05
  • CYH 0.04
  • Stochastic Oscillator
  • EOLS 0.65
  • CYH 72.22

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

About CYH Community Health Systems Inc.

Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.

Share on Social Networks: